Harvard Medical School's Beth Israel Deaconess Medical Center has appointed MIT TLO's Tod Woolf as executive director of the Technology Ventures Office.
Beth Israel Deaconess Medical Center (BIDMC), a patient care, teaching and research affiliate of Harvard University’s Medical School, appointed Tod Woolf as executive director of its Technology Ventures Office on Friday.
Woolf will be responsible for all aspects of the centre’s intellectual property management and commercialisation efforts. He will also help identify and pursue pre-clinical strategic partnerships.
Before joining BIDMC, Woolf was a technology licensing officer for biotechnology at Massachusetts Institute of Technology for three years.
He was previously founder and president of biopharmaceutical business and technology development consultancy Ipifini from 2004 to 2016.
BIDMC is part of health system Beth Israel Lahey Health, which consists of a range of academic medical centres, teaching hospitals, community and speciality hospitals boasting more than 4,000 doctors between them.
Gyongyi Szabo, chief academic officer at BIDMC and faculty dean for academic programs at Harvard Medical School, said: “We are pleased to welcome Dr Woolf to BIDMC and to his vital role leading the Technology Ventures Office.
“Dr Woolf’s 25-plus years of leadership experience in biotechnology will be instrumental to fostering collaborations that lead to far-reaching advances in patient care.”
